Intermittent intravenous therapy: A comparison of two flushing solutions
Jeannette Robertson
Nurse Researcher, Princess Margaret Hospital for Children, Perth WA
PP: 174 - 179
Abstract
In the light of evidence which linked heparin induced thrombocytopoenia (HIT) to the prolonged flushing of intermittent IV cannula with heparinised saline, a randomised control trial was mounted to determine whether this solution was a superior flushing agent to normal saline. 152 inpatients between the ages of 2 months and 18 years were allocated to a control group which had heparinised saline prescribed as a flushing agent, or an experimental group which was prescribed normal saline. Each day IV sites were examined for signs of phlebitis and on removal each cannula was flushed to check for fibrin. In total 200 cannulae representing 510 IV days were assessed.
No significant differences were detected in either the duration of IV therapy, the patency of the IV line or the incidence of phlebitis when normal saline was used to flush the IV cannulae. On chi square testing however, highly significant associations emerged between the incidence of phlebitis and the use of the IV antibiotics tobramycin (p=0.05) and/or Timentin (p=0.008). In addition, young children were found to have a significant higher incidence of blocked cannulae - regardless of the flushing solution used.
Keywords
infusions, intravenous, intravenous therapy
References
Cyganski J, Donahue J and Heaton J (1987) The case for the heparin flush. American Journal of Nursing 87(June): 796-797.
Dean T and Ridley P (1985) Use of 0.9% sodium chloride injection without heparin for maintaining indwelling intermittent injection sites. Clinical Pharmacy 4(Sept/Oct): 488.
Epperson E (1984) Efficacy of 0.9% sodium chloride injection with and without heparin for maintaining indwelling, intermittent injection sites. Clinical Pharmacy 3(Nov/Dec): 626-629.
Ferraro J, Guanci R and Stoneburger R (1985) Use of 0.9% sodium chloride injection without heparin for maintaining indwelling, intermittent injection sites. Clinical Pharmacy 4(Sept-Oct): 488-489.
Friedman L, Furberg C and DeMets D (1985) Fundamentals of clinical trials 2nd edn. PSG Publishing, Littleton, Massachusetts.
Garrelts J, LaRocca J, Ast D, Smith D and Sweet D (1989) Comparison of heparin and 0.9% sodium chloride injection for maintaining patency of indwelling intermittent IV devices. Clinical Pharmacy 8(Jan): 34-39.
Hamilton R, Plis J, Clay C and Sylvan L (1988) Heparin sodium versus 0.9% sodium chloride injection for maintaining patency of indwelling, intermittent infusion devices. Clinical Pharmacy 8(Jun): 439-443.
Hook M (1990) Heparin v normal saline. Journal of Intravenous Nursing 13(3): 150-151.
eContent Home
